DE69103968T2
(de)
*
|
1990-06-15 |
1995-03-23 |
Synthelabo |
2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
|
FR2663336B1
(fr)
|
1990-06-18 |
1992-09-04 |
Adir |
Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
CA2241567A1
(en)
|
1996-01-17 |
1997-07-24 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
|
DE69737479D1
(de)
|
1996-08-30 |
2007-04-26 |
Novo Nordisk As |
Glp-1 derivate
|
CN1190434C
(zh)
|
1996-12-31 |
2005-02-23 |
雷迪实验室有限公司 |
新的杂环化合物、其制备方法和含有它们的药物组合物及其在治疗糖尿病和相关疾病中的应用
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
CA2294830A1
(en)
|
1997-07-16 |
1999-01-28 |
John Bondo Hansen |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
CO4970713A1
(es)
|
1997-09-19 |
2000-11-07 |
Sanofi Synthelabo |
Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
|
BR9908706A
(pt)
|
1998-03-12 |
2000-11-21 |
Teijin Ltd |
Derivado de benzofuril-alfa-pirona, composição farmacêutica, acentuador de metabolismo de lipìdeos, inibidor de biossìntese de triglicerìdeos, agente redutor de triglicerìdeos do sangue, agente elevador de hdl do sangue, agente profilático para a arteriosclerose, e, agente de tratamento para a arteriosclerose
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
GB9900416D0
(en)
|
1999-01-08 |
1999-02-24 |
Alizyme Therapeutics Ltd |
Inhibitors
|
WO2000058491A1
(fr)
|
1999-03-25 |
2000-10-05 |
The Kitasato Institute |
Nouvelles substances kf-1040t4a, kf-1040t4b, kf-1040t5a et kf-1040t5b et leur procede de production
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
WO2000063208A1
(en)
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
AU3957600A
(en)
|
1999-04-26 |
2000-11-10 |
Boehringer Ingelheim International Gmbh |
Piperidyl-imidazole derivatives, their preparations and therapeutic uses
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
PT1177176E
(pt)
|
1999-04-28 |
2006-08-31 |
Aventis Pharma Gmbh |
Derivados de acidos triarilicos como ligandos de receptores ppar.
|
WO2000066585A1
(en)
|
1999-04-30 |
2000-11-09 |
Neurogen Corporation |
9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
|
GB9911863D0
(en)
|
1999-05-21 |
1999-07-21 |
Knoll Ag |
Therapeutic agents
|
CA2374239A1
(en)
|
1999-06-15 |
2000-12-21 |
Albert J. Robichaud |
Substituted heterocycle fused gamma-carbolines
|
PL206826B1
(pl)
|
1999-06-23 |
2010-09-30 |
Sanofi Aventis Deutschland |
Podstawione benzimidazole
|
US7235625B2
(en)
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
EP1204654B1
(en)
|
1999-07-29 |
2003-07-23 |
Eli Lilly And Company |
Benzofurylpiperazines: 5-ht2c serotonin receptor agonists
|
HUP0202472A3
(en)
|
1999-09-01 |
2005-03-29 |
Aventis Pharma Gmbh |
Sulfonyl carboxiamide derivatives, method for their production and their use as medicaments
|
ATE329920T1
(de)
|
1999-09-10 |
2006-07-15 |
Novo Nordisk As |
Modulatoren der protein tyrosin phosphatase (ptpases)
|
AU7476800A
(en)
|
1999-09-10 |
2001-04-10 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
SK287074B6
(sk)
|
2000-03-23 |
2009-11-05 |
Solvay Pharmaceuticals B. V. |
4,5-Dihydro-1H-pyrazolové deriváty, spôsoby ich prípravy, medziprodukty a ich použitie
|
DE60132181D1
(de)
|
2000-03-31 |
2008-02-14 |
Pfizer Prod Inc |
Malonsäureamide sowie deren derivate als thyroidrezeptor liganden
|
CN1430603A
(zh)
|
2000-04-28 |
2003-07-16 |
旭化成株式会社 |
新型双环化合物
|
WO2001085693A1
(fr)
|
2000-05-11 |
2001-11-15 |
Banyu Pharmaceutical Co., Ltd. |
Dérivés n-acyltétrahydroisoquinoline
|
ES2252230T3
(es)
|
2000-05-11 |
2006-05-16 |
Bristol-Myers Squibb Company |
Analogos de tetrahidroisoquinolina utiles como secretores de la hormona del crecimiento.
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
AU6497701A
(en)
|
2000-05-30 |
2001-12-11 |
Merck & Co Inc |
Melanocortin receptor agonists
|
US6395784B1
(en)
|
2000-06-07 |
2002-05-28 |
Bristol-Myers Squibb Company |
Benzamide ligands for the thyroid receptor
|
AU2001272476A1
(en)
|
2000-06-16 |
2001-12-24 |
Smithkline Beecham Plc |
Piperidines for use as orexin receptor antagonists
|
EP1246847A2
(en)
|
2000-07-05 |
2002-10-09 |
Synaptic Pharmaceutical Corporation |
Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
|
JP2004504303A
(ja)
|
2000-07-05 |
2004-02-12 |
シナプティック・ファーマスーティカル・コーポレーション |
選択的メラニン凝集ホルモン−1(mch1)受容体アンタゴニストおよびその使用
|
DE60106641T2
(de)
|
2000-11-03 |
2005-12-01 |
Wyeth |
Cyclopenta[b][1,4] diazepino[6,7,1-hi]indole als 5ht2c antagonisten
|
JP2004513164A
(ja)
|
2000-11-10 |
2004-04-30 |
イーライ・リリー・アンド・カンパニー |
3−置換オキシインドールβ3アゴニスト
|
HUP0004741A2
(hu)
|
2000-11-28 |
2002-12-28 |
Sanofi-Synthelabo |
Kémiai eljárás tiazolszármazékok előállítására és új intermedier
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
US6653300B2
(en)
|
2000-12-21 |
2003-11-25 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
KR20030063462A
(ko)
|
2000-12-21 |
2003-07-28 |
아벤티스 파마 도이칠란트 게엠베하 |
디페닐 아제티디논 유도체, 이의 제조 방법, 이들화합물을 함유하는 약제 및 이의 용도
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
NZ524633A
(en)
|
2001-03-22 |
2005-02-25 |
Solvay Pharmaceuticals B |
4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
|
AU2002305323A1
(en)
|
2001-05-04 |
2002-11-18 |
Tularik Inc. |
Fused heterocyclic compounds
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
IL159221A0
(en)
|
2001-06-28 |
2004-06-01 |
Algat Sherutey Gimur Teufati |
Treatment for improved magnesium surface corrosion-resistance
|
EA005934B1
(ru)
|
2001-07-05 |
2005-08-25 |
Х. Лундбекк А/С |
Замещённые анилиновые пиперидины в качестве селективных антагонистов мсн
|
WO2003007887A2
(en)
|
2001-07-20 |
2003-01-30 |
Merck & Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
JP2005504043A
(ja)
|
2001-08-10 |
2005-02-10 |
パラチン テクノロジーズ インク. |
生物学的に活性な金属ペプチド類のペプチド模倣体類
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7732451B2
(en)
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
US7655658B2
(en)
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP4436129B2
(ja)
|
2001-08-31 |
2010-03-24 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
ジアリールシクロアルキル誘導体、その製造法及びppar−活性剤としてのその使用
|
US7109216B2
(en)
|
2001-09-21 |
2006-09-19 |
Solvay Pharmaceuticals B.V. |
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
SI1429761T1
(sl)
|
2001-09-21 |
2007-02-28 |
Solvay Pharm Bv |
Novi 4,5-dihidro-1h-pirazolni derivati s cb1-antagonisticno aktivnostjo
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
CA2461144A1
(en)
|
2001-09-24 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
Preparation and use of pyrrole derivatives for treating obesity
|
PE20030547A1
(es)
|
2001-09-24 |
2003-08-18 |
Bayer Corp |
Derivados de imidazol para el tratamiento de la obesidad
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
PL370447A1
(en)
|
2001-11-22 |
2005-05-30 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
KR20050044517A
(ko)
|
2001-11-22 |
2005-05-12 |
바이오비트럼 에이비 |
11-베타-히드록시 스테로이드 탈수소효소 유형 1 의억제제
|
WO2003043999A1
(en)
|
2001-11-22 |
2003-05-30 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
GB0202015D0
(en)
|
2002-01-29 |
2002-03-13 |
Hoffmann La Roche |
Piperazine Derivatives
|
US7329683B2
(en)
|
2002-02-01 |
2008-02-12 |
Merck & Co., Inc. |
11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
|
US20050124652A1
(en)
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
ES2246481T3
(es)
|
2002-02-27 |
2006-02-16 |
Pfizer Products Inc. |
Inhibidores de la acc.
|
PT1483265E
(pt)
|
2002-03-05 |
2007-01-31 |
Lilly Co Eli |
Derivados de purina como inibidores de quinase
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
AU2003226149A1
(en)
|
2002-04-05 |
2003-10-27 |
Merck & Co., Inc. |
Substituted aryl amides
|
DE10215907A1
(de)
|
2002-04-11 |
2003-11-06 |
Aventis Pharma Gmbh |
Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
GB0208384D0
(en)
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
FR2838438A1
(fr)
|
2002-04-11 |
2003-10-17 |
Sanofi Synthelabo |
Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant
|
JP4459629B2
(ja)
|
2002-04-12 |
2010-04-28 |
メルク エンド カムパニー インコーポレーテッド |
二環式アミド
|
AU2003234929A1
(en)
|
2002-05-17 |
2003-12-02 |
Kyowa Hakko Kogyo Co., Ltd. |
Therapeutic agent for diabetes
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
AU2003248888A1
(en)
|
2002-07-09 |
2004-01-23 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
EP1539730A4
(en)
|
2002-07-09 |
2007-03-28 |
Fasgen Inc |
NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD FOR THEIR APPLICATION
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
CN1304371C
(zh)
|
2002-07-12 |
2007-03-14 |
塞诺菲-安万特德国有限公司 |
杂环取代的苯甲酰脲、其药物和制备药物的用途
|
IL150914A
(en)
|
2002-07-25 |
2014-04-30 |
Zamir Tribelsky |
A method for hydro-optronio photochemical treatment of liquids
|
DE10233817A1
(de)
|
2002-07-25 |
2004-02-12 |
Aventis Pharma Deutschland Gmbh |
Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US20050272036A1
(en)
|
2002-07-27 |
2005-12-08 |
Barton Peter J |
Ketones
|
ES2301833T3
(es)
|
2002-07-29 |
2008-07-01 |
Hoffmann La Roche |
Derivados de benzodioxol.
|
AU2003250539A1
(en)
|
2002-08-07 |
2004-02-25 |
Mitsubishi Pharma Corporation |
Dihydropyrazolopyridine compounds
|
GB0219022D0
(en)
|
2002-08-15 |
2002-09-25 |
Karobio Ab |
Novel thyromimetic compounds
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
SE0202539D0
(sv)
|
2002-08-27 |
2002-08-27 |
Astrazeneca Ab |
Compounds
|
WO2004022544A1
(fr)
|
2002-09-05 |
2004-03-18 |
Aventis Pharma S.A. |
Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
|
US7414057B2
(en)
|
2002-09-11 |
2008-08-19 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
WO2004029204A2
(en)
|
2002-09-27 |
2004-04-08 |
Merck & Co., Inc. |
Substituted pyrimidines
|
BR0315166A
(pt)
|
2002-10-11 |
2005-08-16 |
Astrazeneca Ab |
Uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para produzir um efeito inibidor de 11betahsd1 em um animal de sangue quente, tal como o homem, que necessita de tratamento
|
DE10247680B4
(de)
|
2002-10-12 |
2005-09-01 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
|
EP1556373A1
(en)
|
2002-10-18 |
2005-07-27 |
Pfizer Products Inc. |
Cannabinoid receptor ligands and uses thereof
|
BR0315381A
(pt)
|
2002-10-18 |
2005-08-23 |
Merck & Co Inc |
Composto ou um sal farmaceuticamente aceitável deste, composição farmacêutica, e, métodos para inibir a atividade da enzima dipeptidil peptidase-iv em um mamìfero em necessidade disto, para tratar diabetes em um mamìfero em necessidade disto, para tratar diabete não dependente de insulina (tipo 2) em um mamìfero em necessidade disto, para tratar hiperglicemia em um mamìfero em necessidade disto, para tratar a obesidade em um mamìfero em necessidade disto, para tratar um ou mais distúrbios de lipìdios selecionados do grupo de dislipidemia, hiperlipidemia, hipertrigliceridemia, hipercolesterolemia, hdl baixo e ldl alto em um mamìfero em necessidade disto, e para tratar em um mamìfero em necessidade disto uma ou mais condições
|
US7132539B2
(en)
|
2002-10-23 |
2006-11-07 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
EP1556040A1
(en)
|
2002-10-24 |
2005-07-27 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
AU2003291342A1
(en)
|
2002-11-05 |
2004-06-07 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
|
AU2003276458A1
(en)
|
2002-11-07 |
2004-06-07 |
Astrazeneca Ab |
2-oxo-ethanesulfonamide derivates
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
WO2004058145A2
(en)
|
2002-12-19 |
2004-07-15 |
Merck & Co., Inc. |
Substituted amides
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
FR2849032B1
(fr)
|
2002-12-23 |
2006-04-28 |
Sanofi Synthelabo |
Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
|
GB0230088D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
WO2004063179A1
(en)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Substituted arylcyclopropylacetamides as glucokinase activators
|
US8293751B2
(en)
|
2003-01-14 |
2012-10-23 |
Arena Pharmaceuticals, Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
EP1594863A1
(en)
|
2003-02-11 |
2005-11-16 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
WO2004072076A1
(de)
|
2003-02-13 |
2004-08-26 |
Aventis Pharma Deutschland Gmbh |
Substituierte hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
KR20050100686A
(ko)
|
2003-02-13 |
2005-10-19 |
사노피-아벤티스 도이칠란트 게엠베하 |
질소-치환된헥사하이드로피라지노[1,2-a]피리미딘-4,7-디온 유도체,이의 제조방법 및 의약으로서의 이의 용도
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE602004011603T2
(de)
|
2003-02-19 |
2009-01-29 |
F. Hoffmann-La Roche Ag |
Sulfonamidsubstituierte xanthinderivate zur verwendung als pepck-inhibitoren
|
WO2004078716A1
(en)
|
2003-03-03 |
2004-09-16 |
Merck & Co. Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
EP1460069A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
EP1460075A1
(en)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
DE602004021786D1
(de)
|
2003-03-26 |
2009-08-13 |
Actelion Pharmaceuticals Ltd |
Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten
|
AU2004226452B2
(en)
|
2003-03-26 |
2008-07-24 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
DE602004025220D1
(de)
|
2003-04-11 |
2010-03-11 |
High Point Pharmaceuticals Llc |
Pharmazeutische verwendungen von kondensierten 1,2,4-triazolen
|
EP1618112A1
(en)
|
2003-04-11 |
2006-01-25 |
SmithKline Beecham Corporation |
Heterocyclic mchr1 antagonists
|
WO2004089367A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
WO2004089896A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
US20060200534A1
(en)
|
2003-04-25 |
2006-09-07 |
Takahiro Nagai |
Multi-medium information sharing system
|
DE602004024880D1
(de)
|
2003-05-01 |
2010-02-11 |
Vernalis Res Ltd |
Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten
|
BRPI0409959A
(pt)
|
2003-05-01 |
2006-04-25 |
Vernalis Res Ltd |
uso de derivados de azetidinacarboxamida em terapia
|
WO2004096794A1
(en)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
|
WO2004099157A1
(en)
|
2003-05-07 |
2004-11-18 |
Pfizer Products Inc. |
Cannabinoid receptor ligands and uses thereof
|
EP1626717A4
(en)
|
2003-05-09 |
2009-09-09 |
Merck & Co Inc |
BENZIMIDAZOLE, COMPOSITIONS AND METHOD OF ADMINISTRATION CONTAINING SUCH COMPOUNDS
|
AR044152A1
(es)
|
2003-05-09 |
2005-08-24 |
Bayer Corp |
Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
EP1631558A1
(en)
|
2003-05-21 |
2006-03-08 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
|
CA2523015A1
(en)
|
2003-05-23 |
2004-12-29 |
Chiron Corporation |
Guanidino-substituted quinazolinone compounds as mc4-r agonists
|
CN1795181A
(zh)
|
2003-05-29 |
2006-06-28 |
麦克公司 |
用作11β-羟基类固醇脱氢酶-1抑制剂的***衍生物
|
WO2004106343A2
(en)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
UA83230C2
(ru)
|
2003-06-11 |
2008-06-25 |
Мерк Энд Ко., Инк. |
Замещенные производные 3-алкил- и 3-алкенилазетидинов
|
CA2529353A1
(en)
|
2003-06-13 |
2005-01-06 |
Janssen Pharmaceutica N.V. |
Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
JP2006527770A
(ja)
|
2003-06-18 |
2006-12-07 |
アストラゼネカ アクチボラグ |
Cb1モジュレーターとしての2−置換5,6−ジアリール−ピラジン誘導体
|
CA2530024A1
(en)
|
2003-06-19 |
2005-01-06 |
Eli Lilly And Company |
Melanocortin receptor 4(mc4) agonists and their uses
|
CA2528785A1
(en)
|
2003-06-20 |
2005-01-06 |
Matthias Heinrich Nettekoven |
2-amidobenzothiazoles as cb1 receptor inverse agonists
|
FR2856683A1
(fr)
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
WO2004113310A1
(en)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
|
WO2005001921A1
(ja)
|
2003-06-27 |
2005-01-06 |
Nec Corporation |
薄膜トランジスタ、薄膜トランジスタ基板、電子機器及び多結晶半導体薄膜の製造方法
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
WO2005000974A2
(en)
|
2003-06-27 |
2005-01-06 |
Day-Glo Color Corp. |
Water-based spray marking composition
|
WO2005005453A2
(en)
|
2003-07-09 |
2005-01-20 |
Forbes Medi-Tech Inc. |
Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions.
|
DE10331074A1
(de)
|
2003-07-09 |
2005-02-03 |
Conti Temic Microelectronic Gmbh |
Sensoranordnung zur Abstands- und/oder Geschwindigkeitsmessung
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
US20050014786A1
(en)
|
2003-07-11 |
2005-01-20 |
Chongqing Sun |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
FR2857570A1
(fr)
|
2003-07-18 |
2005-01-21 |
Didier Leandri |
Dispositif de suspension de verres a pied autour d'un seau utilisable pour le rafraichissement des boissons
|
WO2005009950A2
(en)
|
2003-07-22 |
2005-02-03 |
Merck & Co., Inc. |
Piperidine derivatives as melanocortin-4 receptor agonists
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
JP2007501789A
(ja)
|
2003-08-07 |
2007-02-01 |
メルク エンド カムパニー インコーポレーテッド |
11−β−ヒドロキシステロイドデヒドロゲナーゼ−1の阻害剤としてのピラゾールカルボキサミド
|
JP2007501801A
(ja)
|
2003-08-07 |
2007-02-01 |
日本たばこ産業株式会社 |
ピロロ[1,2−b]ピリダジン誘導体
|
TW200510324A
(en)
|
2003-08-11 |
2005-03-16 |
Lilly Co Eli |
6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
|
JP2007502283A
(ja)
|
2003-08-13 |
2007-02-08 |
アムジェン インコーポレイテッド |
メラニン凝集ホルモン受容体アンタゴニスト
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
WO2005021495A2
(en)
|
2003-08-25 |
2005-03-10 |
Microbia Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
WO2005021497A2
(en)
|
2003-08-28 |
2005-03-10 |
Microbia, Inc. |
Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
|
CN1956949A
(zh)
|
2003-09-18 |
2007-05-02 |
默克公司 |
取代的磺酰胺
|
TWI336697B
(en)
|
2003-09-19 |
2011-02-01 |
Solvay Pharm Bv |
Thiazole derivatives as cannabinoid receptor modulators
|
BRPI0414539B8
(pt)
|
2003-09-19 |
2021-05-25 |
Novo Nordisk As |
composto, composição farmacêutica, e, uso de um composto
|
US20050070712A1
(en)
|
2003-09-26 |
2005-03-31 |
Christi Kosogof |
Pyrimidine derivatives as ghrelin receptor modulators
|
CA2539596A1
(en)
|
2003-09-30 |
2005-04-07 |
Kilian Waldemar Conde-Frieboes |
Melanocortin receptor agonists
|
US7244843B2
(en)
|
2003-10-07 |
2007-07-17 |
Bristol-Myers Squibb Company |
Modulators of serotonin receptors
|
EP1522541A1
(en)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Novel hypocholesterolemic compounds
|
WO2005042516A2
(en)
|
2003-10-22 |
2005-05-12 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
GB0325192D0
(en)
|
2003-10-29 |
2003-12-03 |
Astrazeneca Ab |
Method of use
|
JP2007509963A
(ja)
|
2003-10-30 |
2007-04-19 |
メルク エンド カムパニー インコーポレーテッド |
抗高コレステロール血漿薬としての2−アゼチジノン
|
WO2005042692A2
(en)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
ES2291951T3
(es)
|
2003-11-07 |
2008-03-01 |
F. Hoffmann-La Roche Ag |
Derivados de benzo (b) (1,4) dioxepina.
|
PL1682499T3
(pl)
|
2003-11-10 |
2008-01-31 |
Microbia Inc |
4-Biarylilo-1-fenyloazetydyn-2-ony
|
US7989634B2
(en)
|
2003-11-12 |
2011-08-02 |
Lg Life Sciences Ltd. |
Melanocortin receptor agonists
|
KR20050045927A
(ko)
|
2003-11-12 |
2005-05-17 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
MXPA06005736A
(es)
|
2003-11-19 |
2006-12-14 |
Chiron Corp |
Compuestos de quinazolinona con bioacumulacion reducida.
|
EP1538159A1
(en)
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
|
US20070155660A1
(en)
|
2003-12-10 |
2007-07-05 |
Marsh Donald J |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
WO2005065680A1
(en)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Cyclic guanidines, compositions containing such compounds and methods of use
|
TW200530246A
(en)
|
2003-12-19 |
2005-09-16 |
Bristol Myers Squibb Co |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
EA010298B1
(ru)
|
2003-12-19 |
2008-08-29 |
Биовитрум Аб (Пабл) |
Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
|
EP1697370B1
(en)
|
2003-12-19 |
2007-04-25 |
Bristol-Myers Squibb Company |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
EP1557417B1
(en)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
SA04250427A
(ar)
|
2003-12-23 |
2005-12-03 |
استرازينيكا ايه بي |
مشتقات ثاني فينيل أزيتيدون
|
EP1699760B1
(en)
|
2003-12-23 |
2017-05-17 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
JP4958560B2
(ja)
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Gpcr受容体作動薬としてのヘテロ環誘導体
|
CN1901917A
(zh)
|
2004-01-06 |
2007-01-24 |
詹森药业有限公司 |
作为糖原磷酸化酶抑制剂用于治疗糖尿病和肥胖症的(3-氧代-3,4-二氢-喹喔啉-2-基-氨基)-苯甲酰胺衍生物和相关化合物
|
JP2005206492A
(ja)
|
2004-01-21 |
2005-08-04 |
Sankyo Co Ltd |
スルホンアミド化合物
|
DE102004003812A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004003811A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2005075450A2
(en)
|
2004-01-28 |
2005-08-18 |
F. Hoffmann-La Roche Ag |
Spiro-benzodioxoles and their use as cb1 antagonists
|
EP1718309A2
(en)
|
2004-01-30 |
2006-11-08 |
Japan Tobacco, Inc. |
Anorectic compounds
|
WO2005073229A1
(de)
|
2004-01-31 |
2005-08-11 |
Sanofi-Aventis Deutschland Gmbh |
7-phenylamino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
BRPI0507801A
(pt)
|
2004-02-17 |
2007-07-10 |
Esteve Labor Dr |
compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
|
WO2005080360A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Compounds
|
CA2553372A1
(en)
|
2004-02-19 |
2005-09-01 |
Solvay Pharmaceuticals B.V. |
Imidazoline derivatives having cb1-antagonistic activity
|
GB0403780D0
(en)
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
CA2555331C
(en)
|
2004-02-20 |
2011-01-04 |
Astrazeneca Ab |
Therapeutic agents
|
WO2005080424A2
(en)
|
2004-02-23 |
2005-09-01 |
Rheoscience A/S |
Peptide yy analogues
|
EA011011B1
(ru)
|
2004-02-25 |
2008-12-30 |
Эли Лилли Энд Компани |
6-ЗАМЕЩЁННЫЕ 2,3,4,5-ТЕТРАГИДРО-1H-БЕНЗО[d]АЗЕПИНЫ В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ 5-HT
|
US7902191B2
(en)
|
2004-02-25 |
2011-03-08 |
Eli Lilly And Company |
Histamine H3 receptor antagonists, preparation and therapeutic uses
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
US8058245B2
(en)
|
2004-03-04 |
2011-11-15 |
Kissei Pharmaceutical Co., Ltd. |
Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
|
US7732456B2
(en)
|
2004-03-05 |
2010-06-08 |
Banyu Pharmaceutical Co., Ltd. |
Pyridone derivative
|
PL1751131T3
(pl)
|
2004-03-10 |
2009-04-30 |
Janssen Pharmaceutica Nv |
Arylopiperydyny lub -piperazyny podstawione 5-członowymi heterocyklilami jako inhibitory MTP
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
WO2005092836A1
(en)
*
|
2004-03-15 |
2005-10-06 |
Eli Lilly And Company |
Opioid receptor antagonists
|
GB0406378D0
(en)
|
2004-03-22 |
2004-04-21 |
Karobio Ab |
Novel pharmaceutical compositions
|
AU2005230864A1
(en)
|
2004-03-29 |
2005-10-20 |
Merck Sharp & Dohme Corp. |
Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
EP1586318A1
(en)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiadiazolidinones as GSK-3 inhibitors
|
WO2005097129A2
(en)
|
2004-04-05 |
2005-10-20 |
Takeda Pharmaceutical Company Limited |
6-azaindole compound
|
EP1736467A4
(en)
|
2004-04-06 |
2009-07-01 |
Dainippon Sumitomo Pharma Co |
NEW SULFONIC ACID AMID DERIVATIVE
|
JP2007532511A
(ja)
|
2004-04-09 |
2007-11-15 |
スミスクライン ビーチャム コーポレーション |
低用量医薬品
|
FR2868780B1
(fr)
|
2004-04-13 |
2008-10-17 |
Sanofi Synthelabo |
Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique
|
WO2005108370A1
(ja)
|
2004-04-16 |
2005-11-17 |
Ajinomoto Co., Inc. |
ベンゼン化合物
|
EP1604988A1
(en)
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
|
CN1950374A
(zh)
|
2004-05-25 |
2007-04-18 |
辉瑞产品公司 |
四氮杂苯并[e]甘菊环衍生物及其类似物
|
US7442693B2
(en)
|
2004-05-28 |
2008-10-28 |
Smithkline Beecham Corporation |
Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
MXPA06014415A
(es)
|
2004-06-24 |
2007-02-19 |
Shionogi & Co |
Compuestos de sulfonamida.
|
AU2005267331A1
(en)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
JP2008504266A
(ja)
|
2004-06-24 |
2008-02-14 |
イーライ リリー アンド カンパニー |
異脂肪血症を治療するための化合物及び方法
|
JP2008504276A
(ja)
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
アミド化合物およびその医薬としての使用
|
TW200606137A
(en)
|
2004-07-02 |
2006-02-16 |
Sankyo Co |
Urea derivatives
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
DE102004034697A1
(de)
|
2004-07-17 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
GB0416728D0
(en)
|
2004-07-27 |
2004-09-01 |
7Tm Pharma As |
Medicinal use of receptor ligands
|
KR100926842B1
(ko)
|
2004-07-28 |
2009-11-13 |
에프. 호프만-라 로슈 아게 |
11-베타-hsd1 억제제로서의 아릴-피리딘 유도체
|
FR2873690B1
(fr)
|
2004-07-29 |
2006-10-13 |
Sanofi Synthelabo |
Derives d'oxopiperidine, leur preparation et leur application en therapeutique
|
DE102004037554A1
(de)
|
2004-08-03 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE602005022089D1
(de)
|
2004-08-06 |
2010-08-12 |
Merck Sharp & Dohme |
Sulfonylverbindungen als hemmer von 11-beta-hydroxysteroiddehydrogenase-1
|
DE102004038268A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038270A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038269A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
AU2005271016A1
(en)
|
2004-08-12 |
2006-02-16 |
Prosidion Limited |
Substituted phenylacetamides and their use as glucokinase activators
|
DE102004039507A1
(de)
|
2004-08-14 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006019020A1
(ja)
|
2004-08-16 |
2006-02-23 |
Sankyo Company, Limited |
置換されたウレア化合物
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CA2577373A1
(en)
|
2004-08-18 |
2006-03-02 |
Metabasis Therapeutics, Inc. |
Novel thiazole inhibitors of fructose 1,6-bisphosphatase
|
CA2576839C
(en)
|
2004-08-30 |
2013-07-02 |
Janssen Pharmaceutica N.V. |
N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
CA2580135A1
(en)
|
2004-09-11 |
2006-03-23 |
Sanofi-Aventis Deutschland Gmbh |
7-azaindoles and their use as ppar agonists
|
MX2007003785A
(es)
|
2004-09-29 |
2007-07-12 |
Kissei Pharmaceutical |
Compuesto heterociclico nitrogenoso 1-(b-d-glicopiranosil)-3, composicion medicinal que contiene el mismo, y uso medicinal del mismo.
|
DK1797042T3
(da)
|
2004-09-29 |
2009-03-02 |
Hoffmann La Roche |
Indozolonderivater som 11B-HSD1-inhibitorer
|
AU2005290436A1
(en)
|
2004-10-01 |
2006-04-13 |
Banyu Pharmaceutical Co.,Ltd |
2-arylcarboxamide-nitrogeneous heterocycle compound
|
WO2006039325A2
(en)
|
2004-10-01 |
2006-04-13 |
Merck & Co., Inc. |
Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
US8030273B2
(en)
|
2004-10-07 |
2011-10-04 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
WO2006037810A2
(en)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Protracted glp-1 compounds
|
WO2006044293A2
(en)
|
2004-10-12 |
2006-04-27 |
Pharmacopeia Drug Discovery, Inc. |
Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
|
JP2008515956A
(ja)
|
2004-10-12 |
2008-05-15 |
ノボ ノルディスク アクティーゼルスカブ |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型活性スピロ化合物
|
JP2006111553A
(ja)
|
2004-10-13 |
2006-04-27 |
Dainippon Sumitomo Pharma Co Ltd |
スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
|
WO2006044174A2
(en)
|
2004-10-13 |
2006-04-27 |
Neurogen Corporation |
Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor
|
CA2584904A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
WO2006045564A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
WO2006049952A1
(en)
|
2004-10-29 |
2006-05-11 |
Eli Lilly And Company |
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
CA2585735A1
(en)
|
2004-11-02 |
2006-05-11 |
Pfizer Inc. |
Novel compounds of substituted and unsubstituted adamantyl amides
|
JP2006131559A
(ja)
|
2004-11-05 |
2006-05-25 |
Takeda Chem Ind Ltd |
含窒素複素環化合物
|
EP1659113A1
(en)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
WO2006051662A1
(ja)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
チアゾール誘導体
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
JP4999698B2
(ja)
|
2004-11-29 |
2012-08-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療または予防用のジペプチジルペプチダーゼ−iv阻害剤としての縮合アミノピペリジン
|
JPWO2006059744A1
(ja)
|
2004-11-30 |
2008-06-05 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
EP1819684B1
(en)
|
2004-12-03 |
2013-08-07 |
Intervet International B.V. |
Substituted piperazines as cb1 antagonists
|
WO2006058923A1
(en)
|
2004-12-03 |
2006-06-08 |
Novo Nordisk A/S |
Heteroaromatic glucokinase activators
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
WO2006068163A1
(ja)
|
2004-12-24 |
2006-06-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
二環性ピロール誘導体
|
EP1833806A1
(en)
|
2004-12-14 |
2007-09-19 |
AstraZeneca AB |
Oxadiazole derivatives as dgat inhibitors
|
WO2006065826A2
(en)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Process to chiral beta amino acid derivatives by asymmetric hydrogenation
|
DE102004060542A1
(de)
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
EP1888544A2
(en)
|
2004-12-17 |
2008-02-20 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
KR20070090192A
(ko)
|
2004-12-18 |
2007-09-05 |
바이엘 헬스케어 아게 |
(5s)-3-[(s)-플루오로(4-트리플루오로메틸페닐)메틸]-5,6,7,8-테트라히드로퀴놀린-5-올 유도체 및 이의 cetp억제제로서의 용도
|
JP2006176443A
(ja)
|
2004-12-22 |
2006-07-06 |
Shionogi & Co Ltd |
メラニン凝集ホルモン受容体アンタゴニスト
|
WO2006067224A2
(en)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
|
EP1831177A1
(en)
|
2004-12-23 |
2007-09-12 |
AstraZeneca AB |
Therapeutic agents
|
EP1833802A2
(en)
|
2004-12-23 |
2007-09-19 |
AstraZeneca AB |
1,2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
WO2006067532A1
(en)
|
2004-12-24 |
2006-06-29 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
NZ556017A
(en)
|
2004-12-24 |
2009-10-30 |
Prosidion Ltd |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
PE20060776A1
(es)
|
2004-12-27 |
2006-09-26 |
Boehringer Ingelheim Pharma |
Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
JP5096927B2
(ja)
|
2004-12-31 |
2012-12-12 |
レディ ユーエス セラピューティックス, インコーポレイテッド |
Cetpインヒビターとしての新規ベンジルアミン誘導体
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7511175B2
(en)
|
2005-01-05 |
2009-03-31 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
WO2006073167A1
(ja)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
DE602006021539D1
(en)
|
2005-01-18 |
2011-06-09 |
Vernalis Res Ltd |
Morpholine als 5ht2c-agonisten
|
AU2006206573B9
(en)
|
2005-01-19 |
2011-09-29 |
Merck Sharp & Dohme Corp. |
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
WO2006082952A1
(ja)
|
2005-02-01 |
2006-08-10 |
Takeda Pharmaceutical Company Limited |
アミド化合物
|
EP1843763A2
(en)
|
2005-02-03 |
2007-10-17 |
Irm, Llc |
Compounds and compositions as ppar modulators
|
EP1851197A2
(en)
|
2005-02-09 |
2007-11-07 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
JP2008530174A
(ja)
|
2005-02-15 |
2008-08-07 |
ノボ ノルディスク アクティーゼルスカブ |
3,4−ジヒドロ−1h−イソキノリン−2−カルボン酸5−アミノピリジン−2−イルエステル
|
CA2597269A1
(en)
|
2005-02-15 |
2006-08-24 |
Kissei Pharmaceutical Co., Ltd. |
1-substituted-7-(beta-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
FR2882365B1
(fr)
|
2005-02-21 |
2007-09-07 |
Sanofi Aventis Sa |
Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
|
TW200640862A
(en)
|
2005-02-25 |
2006-12-01 |
Takeda Pharmaceuticals Co |
Pyridyl acetic acid compounds
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
EP1861416A1
(en)
|
2005-03-09 |
2007-12-05 |
The Board of Trustees of Leland Stanford Junior University |
Obestatin and its uses
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
US20090186834A1
(en)
|
2005-03-24 |
2009-07-23 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
TW200722432A
(en)
|
2005-03-25 |
2007-06-16 |
Sankyo Co |
Thiazole compounds
|
JP4318744B2
(ja)
|
2005-03-31 |
2009-08-26 |
ファイザー・プロダクツ・インク |
シクロペンタピリジンおよびテトラヒドロキノリン誘導体
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
AU2006232871B9
(en)
|
2005-04-01 |
2011-11-24 |
Eli Lilly And Company |
Histamine H3 receptor agents, preparation and therapeutic uses
|
ES2326280T3
(es)
|
2005-04-06 |
2009-10-06 |
F. Hoffmann-La Roche Ag |
Derivados de piridin-3-carboxamida como agonistas inversos de cb1.
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
WO2006113150A1
(en)
|
2005-04-13 |
2006-10-26 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
JP5238492B2
(ja)
|
2005-04-15 |
2013-07-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Sgltインヒビターとしてのグルコピラノシル置換(ヘテロアリールオキシ−ベンジル)−ベンゼン誘導体
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP2008536950A
(ja)
|
2005-04-18 |
2008-09-11 |
ニューロジェン・コーポレーション |
置換ヘテロアリールのcb1拮抗薬
|
CA2605300A1
(en)
|
2005-04-19 |
2006-10-26 |
Bayer Pharmaceuticals Corporation |
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
WO2006111849A1
(en)
|
2005-04-20 |
2006-10-26 |
Pfizer Products Inc. |
Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands
|
EP1873144B1
(en)
|
2005-04-20 |
2014-07-23 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
US20080194494A1
(en)
|
2005-04-26 |
2008-08-14 |
Microbia, Inc. |
4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia
|
US7989445B2
(en)
|
2005-04-28 |
2011-08-02 |
Takeda Pharmaceutical Company Limited |
Thienopyrimidone compound
|
WO2006121861A2
(en)
|
2005-05-05 |
2006-11-16 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
CA2607566A1
(en)
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
|
FR2885627B3
(fr)
|
2005-05-10 |
2007-06-22 |
Espace Production Internationa |
Procede de fabrication de lames de revetement de sol et lames issues de ce procede, feuille decor pour panneaux de revetement de sol
|
WO2006122186A2
(en)
|
2005-05-10 |
2006-11-16 |
Microbia, Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
CN101171231A
(zh)
|
2005-05-10 |
2008-04-30 |
霍夫曼-拉罗奇有限公司 |
二酰基甘油酰基转移酶抑制剂
|
CN101218213A
(zh)
|
2005-05-11 |
2008-07-09 |
迈克罗比亚公司 |
制备酚类4-联苯基氮杂环丁烷-2-酮的方法
|
EP1881850B1
(en)
|
2005-05-13 |
2010-09-29 |
Eli Lilly And Company |
Glp-1 pegylated compounds
|
MX2007014517A
(es)
|
2005-05-17 |
2008-02-11 |
Schering Corp |
Heterociclos como agonistas del receptor de acido nicotinico para el tratamiento de dislipidemia.
|
WO2007044085A2
(en)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Heteroaryl compounds and their uses as therapeutic agents
|
WO2007046867A2
(en)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Piperidine derivatives and their uses as therapeutic agents
|
WO2007046868A2
(en)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Thiazolidine derivatives and their uses as therapeutic agents
|
CA2607441C
(en)
|
2005-05-25 |
2013-02-12 |
Merck & Co., Inc. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
BRPI0611415A2
(pt)
|
2005-05-25 |
2010-09-08 |
Microbia Inc |
ácidos fosfÈnicos de 4-(bifenilil)azetidin-2-ona e processo para a produção dos mesmos
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
CA2610671A1
(en)
|
2005-05-31 |
2006-12-07 |
Astrazeneca Ab |
Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
|
WO2006132436A1
(ja)
|
2005-06-08 |
2006-12-14 |
Japan Tobacco Inc. |
複素環化合物
|
DE102005026762A1
(de)
|
2005-06-09 |
2006-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
DE102005026809A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005026808A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
PE20070112A1
(es)
|
2005-06-10 |
2007-03-08 |
Boehringer Ingelheim Int |
Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos
|
WO2006134317A1
(en)
|
2005-06-11 |
2006-12-21 |
Astrazeneca Ab |
Oxadiazole derivatives as dgat inhibitors
|
WO2006138163A2
(en)
|
2005-06-15 |
2006-12-28 |
Merck & Co., Inc. |
Anti-hypercholesterolemic compounds
|
ES2334518T3
(es)
|
2005-06-16 |
2010-03-11 |
Pfizer, Inc. |
Derivados de n-(piridin-2-il)-sulfonamida.
|
WO2006134481A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
|
WO2006133926A1
(en)
|
2005-06-17 |
2006-12-21 |
Carex Sa |
Pyrazole derivates as cannabinoid receptor modulators
|
US7572808B2
(en)
|
2005-06-17 |
2009-08-11 |
Bristol-Myers Squibb Company |
Triazolopyridine cannabinoid receptor 1 antagonists
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
JP2008543912A
(ja)
|
2005-06-22 |
2008-12-04 |
エフ.ホフマン−ラ ロシュ アーゲー |
(6−フルオロ−ベンゾ[1,3]ジオキソリル)−モルホリン−4−イル−メタノンおよびcb1リガンドとしてのそれらの使用
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
MY148538A
(en)
|
2005-06-22 |
2013-04-30 |
Astrazeneca Ab |
Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
WO2007001939A1
(en)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
|
EP1741709A1
(en)
|
2005-06-28 |
2007-01-10 |
Sanofi-Aventis Deutschland GmbH |
Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
|
WO2007000445A1
(en)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
EP1907383A1
(en)
|
2005-06-30 |
2008-04-09 |
Prosidion Limited |
Gpcr agonists
|
MX2007016545A
(es)
|
2005-06-30 |
2008-02-21 |
Prosidion Ltd |
Agonistas del receptor acoplado a la proteina g.
|
GB0513692D0
(en)
|
2005-07-04 |
2005-08-10 |
Karobio Ab |
Novel pharmaceutical compositions
|
KR100979582B1
(ko)
|
2005-07-05 |
2010-09-01 |
에프. 호프만-라 로슈 아게 |
피리다진 유도체
|
JPWO2007007688A1
(ja)
|
2005-07-08 |
2009-01-29 |
持田製薬株式会社 |
3,5−ジアミノ−1,2,4−トリアゾール誘導体
|
MX2008000294A
(es)
|
2005-07-08 |
2008-04-04 |
Novo Nordisk As |
Activadores de dicicloalquil urea glucocinasa.
|
US20110053910A1
(en)
|
2005-07-09 |
2011-03-03 |
Mckerrecher Darren |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
NZ564743A
(en)
|
2005-07-11 |
2010-03-26 |
Mitsubishi Tanabe Pharma Corp |
An oxime derivative as a glucokinase activating agent and preparations thereof
|
FR2888699A1
(fr)
|
2005-07-13 |
2007-01-19 |
France Telecom |
Dispositif de codage/decodage hierachique
|
JP5281287B2
(ja)
|
2005-07-13 |
2013-09-04 |
Msd株式会社 |
ヘテロ環置換ベンズイミダゾール誘導体
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
MX2008000255A
(es)
|
2005-07-14 |
2008-04-02 |
Novo Nordisk As |
Activadores de urea glucocinasa.
|
ES2326952B1
(es)
|
2005-07-15 |
2010-05-28 |
Laboratorios Del Dr. Esteve, S.A. |
Hidratos de (rac) -n-piperidinil-5-(4-clorofenil)-1-(2,4-diclorofenil)4,5-dihidro-1h-pirazol-3-carboxamida.
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
ES2326461B1
(es)
|
2005-07-15 |
2010-04-19 |
Laboratorios Del Dr. Esteve, S.A. |
Polimorfo de n-priperidinil-5-(4-clorofenil)-1-(2,4-dicloforenil)-4,5-dihidro-1h-pirazol-3-carboxamida y su uso como modulador de receptores de cannabinoides.
|
EP1757587A1
(en)
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted pyrazoline compounds, their preparation and use as medicaments
|
CN101222942A
(zh)
|
2005-07-18 |
2008-07-16 |
诺沃-诺迪斯克有限公司 |
用于治疗肥胖的肽
|
AU2006270145B2
(en)
|
2005-07-19 |
2011-04-14 |
Msd K.K. |
Spirochromanone derivatives as acetyl coenzyme a carboxylase (ACC) inhibitors
|
JP2009501733A
(ja)
|
2005-07-20 |
2009-01-22 |
メルク フロスト カナダ リミテツド |
ステアロイルコエンザイムaデルタ−9デサチュラーゼの阻害剤としてのヘテロ芳香族化合物
|
WO2007015767A1
(en)
|
2005-07-20 |
2007-02-08 |
Eli Lilly And Company |
Pyridine derivatives as dipeptedyl peptidase inhibitors
|
DK1919878T3
(da)
|
2005-07-21 |
2010-10-25 |
Hoffmann La Roche |
Pyridazinonderivater som thyroidhormonreceptoragonister
|
ATE449097T1
(de)
|
2005-07-21 |
2009-12-15 |
Hoffmann La Roche |
Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
|
WO2007015744A1
(en)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Disubstituted thienyl compounds and their use as pharmaceuticals
|
FR2889189A1
(fr)
|
2005-07-28 |
2007-02-02 |
Cerep Sa |
Composes derives d'hydantoine et leur utilistion en tant qu'antagonistes de mchr-1
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
CA2617042A1
(en)
|
2005-07-29 |
2007-02-01 |
Takeda Pharmaceutical Company Limited |
Spiro-cyclic compound
|
ES2326357B1
(es)
|
2005-07-29 |
2010-04-21 |
Laboratorios Del Dr. Esteve, S.A. |
Fase amorfa de una pirazolina sustituida, su preparacion y su uso como medicamento.
|
US7827993B2
(en)
|
2005-07-29 |
2010-11-09 |
Mayo Foundation For Medical Education And Research |
Skin pressure reduction to prevent decubitus ulcers by partial magnetic levitation
|
JP5084503B2
(ja)
|
2005-07-29 |
2012-11-28 |
武田薬品工業株式会社 |
シクロプロパンカルボン酸化合物
|
CN101583352A
(zh)
|
2005-07-29 |
2009-11-18 |
拜尔健康护理有限责任公司 |
治疗肥胖症的联苯氨基酸衍生物的制备和用途
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
AU2006275568A1
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
CA2617654A1
(en)
|
2005-08-04 |
2007-02-08 |
Pfizer Limited |
Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
JP2009504637A
(ja)
|
2005-08-08 |
2009-02-05 |
アストラゼネカ・アクチエボラーグ |
治療薬
|
US20100160286A1
(en)
|
2005-08-09 |
2010-06-24 |
Astrazeneca Uk Limited Ab |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
TW200800217A
(en)
|
2005-08-10 |
2008-01-01 |
Smithkline Beecham Corp |
Novel compounds
|
US20100216758A1
(en)
|
2005-08-10 |
2010-08-26 |
Makoto Ando |
Pyridone Compounds
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
WO2007020502A2
(en)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Cannabinoid receptor ligands and uses thereof
|
BRPI0614834A2
(pt)
|
2005-08-18 |
2011-04-19 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem e usos destas
|
WO2007024004A1
(ja)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
フェニルピリドン誘導体
|
US8017624B2
(en)
|
2005-08-26 |
2011-09-13 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes
|
WO2007026215A1
(en)
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
|
US20090258862A1
(en)
|
2005-08-29 |
2009-10-15 |
Colletti Steven L |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
RU2008112184A
(ru)
|
2005-08-31 |
2009-10-10 |
Астеллас Фарма Инк. (Jp) |
Производное тиазола
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
WO2007028145A2
(en)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
|
US20080300251A1
(en)
|
2005-09-05 |
2008-12-04 |
Sattigeri Jitendra A |
Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
|
US20090264426A1
(en)
|
2005-09-07 |
2009-10-22 |
Shunji Sakuraba |
Bicyclic aromatic substituted pyridone derivative
|
ES2289888B1
(es)
|
2005-09-08 |
2008-12-16 |
Consejo Superior Investig. Cientificas |
Derivados de pirazolcarboxamida, su procedimiento de obtencion y sus aplicaciones como antagonistas/agonistas inversos del receptor cannabinoide cb1 y opioide mu.
|
EP1924546A1
(en)
|
2005-09-14 |
2008-05-28 |
Amgen, Inc |
Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
|
GB0518817D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
GB0518819D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
EP1928874A1
(en)
|
2005-09-16 |
2008-06-11 |
AstraZeneca AB |
Heterobicyclic compounds as glucokinase activators
|
GEP20104966B
(en)
|
2005-09-16 |
2010-04-26 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
EP1931652A2
(en)
|
2005-09-21 |
2008-06-18 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
CN101268099A
(zh)
|
2005-09-21 |
2008-09-17 |
7Tm制药联合股份有限公司 |
用于治疗性干预的y4选择性受体激动剂
|
GB0519294D0
(en)
|
2005-09-21 |
2005-11-02 |
Karobio Ab |
Compounds
|
AU2005337101A1
(en)
|
2005-09-21 |
2007-04-12 |
7Tm Pharma A/S |
Y2 selective receptor agonists for therapeutic interventions
|
MY148863A
(en)
|
2005-09-23 |
2013-06-14 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl pyrazole cannabinoid modulators
|
BRPI0616404A2
(pt)
|
2005-09-23 |
2011-06-21 |
Janssen Pharmaceutica Nv |
moduladores de canabinóide de 3-amido-tetraidro-indazolila substituìdo e uso dos mesmos
|
EP1934206B1
(en)
|
2005-09-29 |
2011-12-14 |
Sanofi |
Phenyl- and pyridyl-i, 2 , 4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
|
RU2008116844A
(ru)
|
2005-09-29 |
2009-11-10 |
Мерк энд Ко., Инк. (US) |
Ацилированные производные спиропиперидина как модуляторы рецептора меланокортина-4
|
JP2007091649A
(ja)
|
2005-09-29 |
2007-04-12 |
Taisho Pharmaceut Co Ltd |
ピリミジン誘導体及びその使用に関連する治療方法
|
CA2624032A1
(en)
|
2005-09-30 |
2007-04-12 |
Merck & Co., Inc. |
Cholesteryl ester transfer protein inhibitors
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
US7758862B2
(en)
|
2005-09-30 |
2010-07-20 |
Compugen Ltd. |
Hepatocyte growth factor receptor splice variants and methods of using same
|
CA2623958C
(en)
|
2005-09-30 |
2013-05-28 |
Banyu Pharmaceutical Co., Ltd. |
2-heteroaryl-substituted indole derivative
|
BRPI0616646A2
(pt)
|
2005-09-30 |
2011-06-28 |
Hoffmann La Roche |
compostos, composição farmacêutica, uso e processo de fabricação de antagonistas de receptores de mch seletivos
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
AU2006297452A1
(en)
|
2005-09-30 |
2007-04-12 |
Merck Sharp & Dohme Corp. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
AR056560A1
(es)
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
FR2891828B1
(fr)
|
2005-10-12 |
2007-12-21 |
Sanofi Aventis Sa |
Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique
|
FR2891829A1
(fr)
|
2005-10-12 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de la 4-amino-quinazoline, leur preparation et leur application en therapeutique
|
FR2891825B1
(fr)
|
2005-10-12 |
2007-12-14 |
Sanofi Aventis Sa |
Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
EP1937677A1
(en)
|
2005-10-17 |
2008-07-02 |
Arcadia Pharmaceuticals Inc. |
Cb-1 modulating compounds and their use
|
DE102005049953A1
(de)
|
2005-10-19 |
2007-04-26 |
Sanofi-Aventis Deutschland Gmbh |
Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
BRPI0617501A2
(pt)
|
2005-10-20 |
2011-07-26 |
Merck & Co Inc |
composto ou um sal ou solvato farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto
|
AU2006305104B2
(en)
|
2005-10-21 |
2009-10-22 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists
|
US7745447B2
(en)
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
US8618115B2
(en)
|
2005-10-26 |
2013-12-31 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
|
WO2007048802A1
(en)
|
2005-10-26 |
2007-05-03 |
Boehringer Ingelheim International Gmbh |
(hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds
|
DE102005052101A1
(de)
|
2005-10-28 |
2007-05-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
JP5137207B2
(ja)
|
2005-11-01 |
2013-02-06 |
アレイ バイオファーマ、インコーポレイテッド |
グルコキナーゼ活性化因子
|
WO2007051810A2
(en)
|
2005-11-01 |
2007-05-10 |
Transtech Pharma |
Pharmaceutical use of substituted amides
|
EP1960386A2
(en)
|
2005-11-01 |
2008-08-27 |
Janssen Pharmaceutica N.V. |
Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
|
US8053431B2
(en)
|
2005-11-01 |
2011-11-08 |
High Point Pharmaceuticals, Llc |
Pharmaceutical use of substituted amides
|
CA2628486A1
(en)
|
2005-11-03 |
2007-05-10 |
Prosidion Ltd. |
Tricyclo substituted amides
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
JP2009514835A
(ja)
|
2005-11-03 |
2009-04-09 |
プロシディオン・リミテッド |
トリシクロ置換型アミド
|
CA2628856A1
(en)
|
2005-11-08 |
2007-05-18 |
Jordi Frigola-Constansa |
Indene derivatives, their preparation and use as medicaments
|
WO2007081755A2
(en)
|
2006-01-09 |
2007-07-19 |
Metabasis Therapeutics, Inc. |
Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
|
UY30082A1
(es)
|
2006-01-11 |
2007-08-31 |
Boehringer Ingelheim Int |
Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
|
EP1987000A2
(en)
|
2006-01-13 |
2008-11-05 |
Schering Corporation |
Diaryl piperidines as cb1 modulators
|
KR20080097426A
(ko)
|
2006-01-18 |
2008-11-05 |
쉐링 코포레이션 |
칸나비노이드 수용체 조절제
|
TW200800920A
(en)
|
2006-02-15 |
2008-01-01 |
Sanofi Aventis |
Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
AU2007214709A1
(en)
|
2006-02-15 |
2007-08-23 |
Sanofi-Aventis |
Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
|
MY149854A
(en)
|
2006-02-15 |
2013-10-31 |
Sanofi Aventis |
Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
|
CN101384605A
(zh)
|
2006-02-15 |
2009-03-11 |
塞诺菲-安万特股份有限公司 |
新的氨基醇取代的芳基噻吩并嘧啶酮、其制备方法以及其作为药物的用途
|
DE102006014685A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen
|
DE102006014688A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
WO2008079610A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Abbott Laboratories |
Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
|